Pacific G13 is a modern hybrid-indica whose lineage remains undocumented. As a sophisticated entry in contemporary breeding, this strain is well-suited for cultivation in both indoor and outdoor environments. Growers should anticipate a moderate difficulty level during the 53-day flowering period, which ultimately produces a high yield. Its genetic influence is verified through notable offspring including BC Love Lettuce, Killer Queen Redux, and LUI 13.

The cannabinoid profile of Pacific G13 is THC-dominant, supported by a dense and complex terpene chemistry. The primary terpene is caryophyllene, followed by myrcene and limonene as secondary and tertiary components. The remaining aromatic profile is rounded out by pinene, humulene, ocimene, nerolidol, linalool, beta-pinene, guaiol, p-cymene, bisabolol, eucalyptol, camphene, and caryophyllene-oxide. This specific chemical array dictates the sensory experience, providing a nuanced aromatic character defined by the interplay of these active compounds.

Regarding physiological effect and functionality, Pacific G13 is observed to promote states of relaxation, calmness, and mental focus. These characteristics make the strain a functional choice for users managing pain, stress, or those seeking assistance with sleep. Through its documented progeny, the strain maintains a consistent presence in modern hybrid lines, establishing Pacific G13 as a predictable genetic contributor for specific therapeutic applications.